First-in-Human Evaluation of18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B is a research paper published in Journal of Nuclear Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1ZIAMH002793-21
PET Radiopharmaceutical Sciences
Fields of Study
Keywords
Sustainable Development Goals